Treatment of hepatic adenomatosis

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Hepatic adenomatosis and hepatocellular adenomas share risk factors and the same pathophysiologic spectrum. The presence in the liver of 10 hepatocellular adenomas defines hepatic adenomatosis. The diagnosis may be established incidentally during a liver radiologic examination in the asymptomatic patient, or after associated right upper quadrant pain, hepatomegaly or liver test abnormalities. Upon the diagnosis of hepatic adenomatosis or either of its lifethreatening complications—hemorrhage and progression to hepatocellular carcinoma—consideration should be given to potential medical, radiologic, and surgical interventions including observation (estrogen and androgen withdrawal), resection, transarterial embolization, radiofrequency ablation, and liver transplantation. The management of patients with hepatic adenomatosis can be challenging. These patients should be ideally referred to centers with expertise in the management of liver diseases.

Original languageEnglish
Article numberA008
Pages (from-to)139-143
Number of pages5
JournalCurrent Hepatitis Reports
Volume14
Issue number2
DOIs
StatePublished - Jun 1 2015

Keywords

  • Hepatic adenomatosis
  • Liver adenomatosis
  • Management of liver adenomatosis
  • Treatment of hepatic adenomatosis

Fingerprint

Dive into the research topics of 'Treatment of hepatic adenomatosis'. Together they form a unique fingerprint.

Cite this